Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Thrombosis × Arginine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 2 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Thrombosis 1 Squamous Cell Carcinoma of Head and Neck 1 Sexuality 1 Sexual Dysfunction, Physiological 1 Salivary Gland Neoplasms 1 Radiation Injuries 1 Protein Metabolism 1 Pain 1 Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Mucositis 1 Malnutrition 1 Hemorrhage 1 Glioblastoma 1 Erectile Dysfunction 1 Disease 1 Diabetes Insipidus 1

Interventions

apixaban 3 Warfarin 2 Dalteparin 2 Aspirin 2 salicylhydroxamic acid 1 fluorescein isothiocyanate-keyhole limpet hemocyanin 1 edoxaban 1 Simvastatin 1 Rivaroxaban 1 Radiotherapy, Conformal 1 Paclitaxel 1 Observation 1 Injections 1 Fondaparinux 1 Enoxaparin 1 Docetaxel 1 Data Collection 1 Dabigatran 1 Clopidogrel 1 Arginine Vasopressin 1 Arginine 1 Anticoagulants 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05293041 2025-03-06

ARG-01

Sahlgrenska University Hospital

Phase 4 Completed

Diabetes Insipidus, Hemorrhage, Pain, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡